JP2000506496A5 - - Google Patents

Download PDF

Info

Publication number
JP2000506496A5
JP2000506496A5 JP1997518215A JP51821597A JP2000506496A5 JP 2000506496 A5 JP2000506496 A5 JP 2000506496A5 JP 1997518215 A JP1997518215 A JP 1997518215A JP 51821597 A JP51821597 A JP 51821597A JP 2000506496 A5 JP2000506496 A5 JP 2000506496A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1997518215A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000506496A (ja
Filing date
Publication date
Priority claimed from US08/556,035 external-priority patent/US5891459A/en
Priority claimed from US08/695,792 external-priority patent/US5852058A/en
Application filed filed Critical
Publication of JP2000506496A publication Critical patent/JP2000506496A/ja
Publication of JP2000506496A5 publication Critical patent/JP2000506496A5/ja
Ceased legal-status Critical Current

Links

JP9518215A 1995-11-09 1996-10-24 内因性酸化窒素の生成又は活性のモデュレーションによる血管機能の増強 Ceased JP2000506496A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/556,035 1995-11-09
US08/556,035 US5891459A (en) 1993-06-11 1995-11-09 Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
US08/695,792 US5852058A (en) 1993-06-11 1996-08-12 Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury
US08/695,792 1996-08-12
PCT/US1996/017241 WO1997016983A1 (en) 1995-11-09 1996-10-24 Enhancement of vascular function by modulation of endogenous nitric oxide production or activity

Publications (2)

Publication Number Publication Date
JP2000506496A JP2000506496A (ja) 2000-05-30
JP2000506496A5 true JP2000506496A5 (enExample) 2004-10-14

Family

ID=27071057

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9518215A Ceased JP2000506496A (ja) 1995-11-09 1996-10-24 内因性酸化窒素の生成又は活性のモデュレーションによる血管機能の増強

Country Status (5)

Country Link
US (1) US5852058A (enExample)
EP (1) EP0871376B1 (enExample)
JP (1) JP2000506496A (enExample)
AT (1) ATE407573T1 (enExample)
WO (1) WO1997016983A1 (enExample)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891459A (en) * 1993-06-11 1999-04-06 The Board Of Trustees Of The Leland Stanford Junior University Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
US6425881B1 (en) 1994-10-05 2002-07-30 Nitrosystems, Inc. Therapeutic mixture useful in inhibiting lesion formation after vascular injury
US20110196039A9 (en) * 1994-10-05 2011-08-11 Kaesemeyer Wayne H Controlled release arginine formulations
US6239172B1 (en) * 1997-04-10 2001-05-29 Nitrosystems, Inc. Formulations for treating disease and methods of using same
DE69637676D1 (de) * 1995-11-09 2008-10-23 Univ R Verwendung von lokal verabreichten Lysine zur VERBESSERUNG DER VASKULAREN FUNKTION
US7914814B2 (en) 1997-09-17 2011-03-29 Strategic Science & Technologies, Llc Topical delivery of arginine of cause beneficial effects
US7629384B2 (en) 1997-09-17 2009-12-08 Strategic Science & Technologies, Llc Topical delivery of L-arginine to cause beneficial effects
ES2549329T3 (es) * 1997-09-17 2015-10-27 Strategic Science & Technologies, Llc Administración tópica de arginina para el tratamiento del dolor
AU3221599A (en) 1998-04-03 1999-10-25 Daily Wellness Company, The Compositions comprising l-arginine, ginseng and gingko biloba for enhancing blood circulation
US6219577B1 (en) 1998-04-14 2001-04-17 Global Vascular Concepts, Inc. Iontophoresis, electroporation and combination catheters for local drug delivery to arteries and other body tissues
US6159942A (en) * 1998-06-19 2000-12-12 Bioenergy, Inc. Compositions for increasing energy in vivo
JP2002539257A (ja) * 1999-03-19 2002-11-19 イーノス・ファーマシューティカルス・インコーポレーテッド 薬剤の脳内生物学的利用率の増加
FR2791571B1 (fr) * 1999-04-02 2002-10-04 Sod Conseils Rech Applic Association inhibiteur(s) de no synthase et antioxydant(s) metabolique(s)
CA2376375C (en) * 1999-06-05 2011-07-12 The Board Of Trustees Of The Leland Stanford Junior University Method and composition for inhibiting cardiovascular cell proliferation
EP1301500B1 (en) 2000-06-22 2007-11-21 Nitromed, Inc. Nitrosated and nitrosylated taxanes, compositions and methods of use
WO2002017898A2 (en) * 2000-09-01 2002-03-07 Sacks Meir S Compositions and methods for inducing vasorelaxation
US6989164B2 (en) 2000-12-22 2006-01-24 The Daily Wellness Company Method and composition for improving male fertility health
US6497885B2 (en) 2000-12-22 2002-12-24 The Daily Wellness Company Method and composition for improving fertility health in female and male animals and humans
US6706274B2 (en) * 2001-01-18 2004-03-16 Scimed Life Systems, Inc. Differential delivery of nitric oxide
US7025734B1 (en) 2001-09-28 2006-04-11 Advanced Cardiovascular Systmes, Inc. Guidewire with chemical sensing capabilities
US7011842B1 (en) 2002-06-21 2006-03-14 Advanced Cardiovascular Systems, Inc. Polycationic peptide coatings and methods of making the same
US7794743B2 (en) 2002-06-21 2010-09-14 Advanced Cardiovascular Systems, Inc. Polycationic peptide coatings and methods of making the same
US8506617B1 (en) 2002-06-21 2013-08-13 Advanced Cardiovascular Systems, Inc. Micronized peptide coated stent
US7217426B1 (en) 2002-06-21 2007-05-15 Advanced Cardiovascular Systems, Inc. Coatings containing polycationic peptides for cardiovascular therapy
US7056523B1 (en) 2002-06-21 2006-06-06 Advanced Cardiovascular Systems, Inc. Implantable medical devices incorporating chemically conjugated polymers and oligomers of L-arginine
US6994867B1 (en) 2002-06-21 2006-02-07 Advanced Cardiovascular Systems, Inc. Biocompatible carrier containing L-arginine
US7033602B1 (en) 2002-06-21 2006-04-25 Advanced Cardiovascular Systems, Inc. Polycationic peptide coatings and methods of coating implantable medical devices
US7070798B1 (en) 2002-06-21 2006-07-04 Advanced Cardiovascular Systems, Inc. Coatings for implantable medical devices incorporating chemically-bound polymers and oligomers of L-arginine
US7094256B1 (en) 2002-12-16 2006-08-22 Advanced Cardiovascular Systems, Inc. Coatings for implantable medical device containing polycationic peptides
JP2007526316A (ja) * 2004-03-01 2007-09-13 ルーメン セラピューティックス リミテッド ライアビリティ カンパニー 疾患を処置するための組成物および方法
US9226909B2 (en) 2004-04-19 2016-01-05 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
JP2007532697A (ja) 2004-04-19 2007-11-15 ストラテジック サイエンス アンド テクノロジーズ， エルエルシー 局所的血流増大の有益な効果
RU2494654C2 (ru) * 2004-12-08 2013-10-10 Унилевер Н.В. Потребительский продукт для улучшения умственной деятельности
WO2006128121A2 (en) 2005-05-27 2006-11-30 The University Of North Carolina At Chapel Hill Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
US8945655B2 (en) * 2007-07-10 2015-02-03 Conopco, Inc. Stable and consumable compositions
US20090155420A1 (en) * 2007-12-12 2009-06-18 Conopco, Inc., D/B/A Unilever Food product with stabilized non-protein amino acids
EP2300603A4 (en) * 2008-06-24 2011-08-03 Micropharma Ltd OXIDE DEVICE AND METHOD FOR WOUND HEALING, TREATMENT OF SKIN DISEASES AND MICROBIAL INFECTIONS
JP2012507993A (ja) * 2008-11-11 2012-04-05 ユニリーバー・ナームローゼ・ベンノートシヤープ 茶組成物
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
US12138268B2 (en) 2009-06-24 2024-11-12 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
WO2010151241A1 (en) 2009-06-24 2010-12-29 Strategic Science & Technologies, Llc Topical composition containing naproxen
CN102481275B (zh) 2009-06-24 2014-07-23 战略科学技术有限公司 含有布洛芬的表面组合物
BR112012003792B1 (pt) 2009-08-21 2020-05-19 Novan Inc composição tópica, e, uso da composição tópica
BR112012003804B1 (pt) 2009-08-21 2019-02-19 Novan, Inc. Curativo para ferimentos, método para formar um curativo para ferimentos, e, kit de curativo para ferimento
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
HRP20201512T1 (hr) 2010-12-29 2020-12-11 Strategic Science & Technologies, Llc Liječenje erektilne disfunkcije i drugih indikacija
WO2012092523A1 (en) 2010-12-29 2012-07-05 Strategic Science & Technologies, Llc Systems and methods for treatment of allergies and other indications
WO2012118829A2 (en) 2011-02-28 2012-09-07 Novan, Inc. Tertiary s-nitrosothiol-modified nitricoxide-releasing xerogels and methods of using the same
JP6423275B2 (ja) 2013-01-21 2018-11-14 協和発酵バイオ株式会社 一酸化窒素濃度上昇剤
RU2579608C1 (ru) * 2014-09-22 2016-04-10 Александр Александрович Кролевец Способ получения нанокапсул l-аргинина и норвалина в альгинате натрия
RU2607589C2 (ru) * 2014-10-06 2017-01-10 Александр Александрович Кролевец Способ получения нанокапсул аминокислот в конжаковой камеди

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1704M (fr) * 1961-12-19 1963-02-18 Aec Chim Organ Biolog Médicament anti-allergique et anti-histaminique a base de β-alanine.
FR2122342B1 (enExample) * 1971-01-21 1974-08-02 Tixier Madeleine
US4029773A (en) * 1973-05-25 1977-06-14 Syntex (U.S.A.) Inc. Composition and method of treating ulcers
US4847240A (en) * 1978-01-16 1989-07-11 The Trustees Of Boston University Method of effecting cellular uptake of molecules
AU8033487A (en) * 1986-09-10 1988-04-07 Dudrick Medical Research Fund I. Ltd. Method and substrate composition for treating atherosclerosis
US5032608A (en) * 1986-09-10 1991-07-16 Dudrick Stanley J Method and substrate composition for treating atherosclerosis
US4920098A (en) * 1986-09-17 1990-04-24 Baxter International Inc. Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases
US5236413B1 (en) * 1990-05-07 1996-06-18 Andrew J Feiring Method and apparatus for inducing the permeation of medication into internal tissue
US5372807A (en) * 1990-05-14 1994-12-13 University Of Medicine And Dentistry Of New Jersey Polymers containing antifibrotic agents, compositions containing such polymers, and methods of preparation and use
US5278189A (en) * 1990-06-04 1994-01-11 Rath Matthias W Prevention and treatment of occlusive cardiovascular disease with ascorbate and substances that inhibit the binding of lipoprotein (A)
EP0533816B1 (en) * 1990-06-15 1995-06-14 Cortrak Medical, Inc. Drug delivery apparatus
US5499971A (en) * 1990-06-15 1996-03-19 Cortrak Medical, Inc. Method for iontophoretically delivering drug adjacent to a heart
AU655780B2 (en) * 1990-10-30 1995-01-12 Clintec Nutrition Company A method and composition for the protection of a metabolic recovery of ischemic cardiac tissue
US5171217A (en) * 1991-02-28 1992-12-15 Indiana University Foundation Method for delivery of smooth muscle cell inhibitors
US5318531A (en) * 1991-06-11 1994-06-07 Cordis Corporation Infusion balloon catheter
JPH05163139A (ja) * 1991-12-12 1993-06-29 Ajinomoto Co Inc 抗動脈硬化剤
WO1994016729A1 (en) * 1993-01-28 1994-08-04 Neorx Corporation Targeted nitric oxide pathway or nitric oxide synthase modulation
US5428070A (en) * 1993-06-11 1995-06-27 The Board Of Trustees Of The Leland Stanford Junior University Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production of activity
JPH08511530A (ja) * 1993-06-11 1996-12-03 ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ 内因性酸化窒素生成又は活性の調節による血管変性疾患の治療
US5482925A (en) * 1994-03-17 1996-01-09 Comedicus Incorporated Complexes of nitric oxide with cardiovascular amines as dual acting cardiovascular agents
US5576287A (en) * 1994-04-29 1996-11-19 Wake Forest University Method for treating acute renal disease and failure
US5681278A (en) * 1994-06-23 1997-10-28 Cormedics Corp. Coronary vasculature treatment method
US5569198A (en) * 1995-01-23 1996-10-29 Cortrak Medical Inc. Microporous catheter

Similar Documents

Publication Publication Date Title
JPH11512298A5 (enExample)
JP2000500228A5 (enExample)
JP2000500033A5 (enExample)
JP2000500445A5 (enExample)
JP2000500440A5 (enExample)
JPH11511015A5 (enExample)
JPH11512430A5 (enExample)
JP2000500145A5 (enExample)
JP2000500155A5 (enExample)
JP2000500406A5 (enExample)
JP2000500361A5 (enExample)
JP2000506496A5 (enExample)
JPH11513371A5 (enExample)
JP2000500192A5 (enExample)
JP2000500112A5 (enExample)
JP2000500226A5 (enExample)
JP2000500051A5 (enExample)
JP2000500407A5 (enExample)
JPH10512148A5 (enExample)
JP2000500397A5 (enExample)
JP2000500019A5 (enExample)
JP2000500166A5 (enExample)
JP2000500125A5 (enExample)
JP2000500044A5 (enExample)
JP2000500090A5 (enExample)